Jump to content

PubMed RSS Feed - - A New Treatment Regimen for Rosacea: OnabotulinumtoxinA.


Recommended Posts

Related Articles

A New Treatment Regimen for Rosacea: OnabotulinumtoxinA.

J Drugs Dermatol. 2012 Dec 1;11(12):e76-9

Authors: Dayan SH, Pritzker RN, Arkins JP

Rosacea is a cutaneous condition with several clinical subtypes that are commonly seen in daily medical practice. There are many different treatment modalities for each of the physical !ndings associated with this disease, and all have varying results. As the use of onabotulinumtoxinA rises, its bene!t in the treatment of a growing number of medical diseases increases. The authors report anecdotal evidence of patients with rosacea experiencing improved symptoms of erythema and "ushing after treatment with intradermal, microdroplets of onabotulinumtoxinA. There were no adverse events reported for any of the treatments. The mechanism of action through a likely neurogenic component to vascular dysfunction, in"ammation, and hypersebaceous activity is reviewed. J Drugs Dermatol. 2012;11(12):e76-e79.

PMID: 23377526 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/PubMed/23377526?dopt=Abstract = URL to article

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use